|
Volumn 23, Issue 7, 2005, Pages 805-
|
When a long shot is worth a shot
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUTARALDEHYDE;
POLYMERIZED HEMOGLOBIN;
RHESUS ANTIGEN;
BLOOD SUBSTITUTE;
BIOTECHNOLOGICAL PRODUCTION;
BLOOD DONOR;
BLOOD GROUP TYPING;
BLOOD SAMPLING;
BLOOD TRANSFUSION;
EMERGENCY SURGERY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MORTALITY;
POLYMERIZATION;
PRIORITY JOURNAL;
SHORT SURVEY;
UNITED STATES;
ARTICLE;
BIOTECHNOLOGY;
CLINICAL TRIAL;
DRUG INDUSTRY;
ECONOMICS;
INJURY;
INVESTMENT;
BIOTECHNOLOGY;
BLOOD SUBSTITUTES;
CLINICAL TRIALS;
DRUG INDUSTRY;
HUMANS;
INVESTMENTS;
UNITED STATES;
WOUNDS AND INJURIES;
|
EID: 24944510379
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0705-805 Document Type: Short Survey |
Times cited : (1)
|
References (0)
|